Mesa Laboratories (NASDAQ:MLAB) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next?

Mesa Laboratories, Inc. (NASDAQ:MLAB) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $76.89 and traded as high as $96.14. Mesa Laboratories shares last traded at $95.56, with a volume of 94,570 shares trading hands.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on MLAB shares. Wells Fargo & Company lifted their price target on shares of Mesa Laboratories from $83.00 to $94.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Zacks Research upgraded Mesa Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, January 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Mesa Laboratories in a research report on Thursday, January 22nd. Finally, Wall Street Zen raised Mesa Laboratories from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 7th. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Mesa Laboratories presently has an average rating of “Reduce” and an average target price of $94.00.

Mesa Laboratories Stock Performance

The company has a debt-to-equity ratio of 0.86, a current ratio of 1.94 and a quick ratio of 1.45. The stock has a fifty day simple moving average of $86.04 and a two-hundred day simple moving average of $76.89. The firm has a market capitalization of $527.97 million, a P/E ratio of 149.31 and a beta of 0.89.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings data on Tuesday, February 3rd. The medical instruments supplier reported $3.07 EPS for the quarter, topping the consensus estimate of $2.41 by $0.66. Mesa Laboratories had a net margin of 1.51% and a return on equity of 22.02%. The company had revenue of $65.13 million during the quarter, compared to the consensus estimate of $63.23 million. On average, research analysts predict that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Saturday, February 28th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, February 27th. Mesa Laboratories’s payout ratio is 100.00%.

Institutional Trading of Mesa Laboratories

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. raised its stake in Mesa Laboratories by 5,366.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 322 shares during the period. Caitong International Asset Management Co. Ltd acquired a new position in shares of Mesa Laboratories during the fourth quarter worth approximately $27,000. Farther Finance Advisors LLC lifted its holdings in shares of Mesa Laboratories by 17,733.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 535 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 532 shares in the last quarter. CWM LLC grew its position in Mesa Laboratories by 48.9% in the 3rd quarter. CWM LLC now owns 597 shares of the medical instruments supplier’s stock valued at $40,000 after purchasing an additional 196 shares during the period. Finally, Kestra Advisory Services LLC bought a new stake in Mesa Laboratories during the 4th quarter valued at $55,000. 90.60% of the stock is owned by institutional investors.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.